Internal: Archive

Swiss railways sets sights on share of British market

This content was published on Sep 1, 2000 The Federal Railways announced in London on Friday that it was teaming up with two British partners to bid for franchises for passenger train services south-west of London. Total Swiss investment could be up to SFr200 million ($114 million). The partners are John Laing Investments and the M40 Trains company. The three companies have already…

Swiss step out as world leaders in saving books

This content was published on Sep 1, 2000 The plant, inaugurated on Friday, will reverse the ageing process of some 3,000 tonnes of books and documents at the Federal Archive and the National Library, through a process known as “Papersave Swiss”. It involves neutralising the acidity in paper using an alkaline substance, and can be applied to any book or document manufactured using…

Fewer houses built in first quarter

This content was published on Sep 1, 2000 Between April and June 7,300 new houses were completed, 300 fewer than in the second quarter of 1999. But taken as a whole the first six months of the year showed a slight increase in new buildings. Between them Switzerland’s five biggest cities accounted for a third of all new housing over the period in…

Leonardo da Vinci as artist, scientist and engineer

This content was published on Sep 1, 2000 The 250 exhibits cover all the fields of science, engineering and the arts to which Leonardo (1452-1519) applied his vision. The exhibition, which has already been seen by three million visitors in 11 cities in Europe, the United States, Asia and South Africa since it began its tour in Germany in 1994, tries to acquaint…

Inflation falls to 10-month low

This content was published on Sep 1, 2000 The federal office for statistics said on Friday the drop was caused by lower transport costs, mainly due to a fall in oil prices, and lower prices for clothing and shoes during the cut-price “sales” period. The price of oil – a key factor in the inflation rate – is set to rise again but…

Basel raises ceiling with new building

This content was published on Sep 1, 2000 The contract for building the 30-story tower was signed on Friday. It will form part of the Basel exhibition site and will house a luxury hotel, and office premises. The cost of construction is estimated at SFr150 million ($86 million) and will be covered by the developing company, Swiss Prime Site. Building work is not…

Swiss see Mozambique as example for Africa

This content was published on Sep 1, 2000 Addressing the conference, the Swiss foreign minister, Joseph Deiss, warned against taking a pessimistic approach to Africa. “There are many different faces to Africa,” he said. “Sierra Leone and the Congo are no more representative of Africa than Northern Ireland or Kosovo are representative of Europe. We must not forget that Africa has success stories,…

Swiss diplomat replaces Icelander at helm of EFTA

This content was published on Aug 31, 2000 Rossier served recently as Switzerland’s envoy to the World Trade Organisation (WTO), EFTA and other international economic bodies in Geneva. EFTA comprises Norway, Iceland and Liechtenstein, as well as Switzerland, which is its major contributor. It was launched as a counterweight to the then European Economic Community in 1965. Over the last years similar free-trade…

Swiss Solar prize rewards green-thinkers

This content was published on Aug 31, 2000 Ogi himself received one of the awards for his “exemplary contribution” to the creation of the prize in 1991 and to the government’s “Energy 2000” energy reduction programme. The awards were handed over in Flums in canton St Gallen, at the premises of the Flumroc company. The firm won the prize in the business category…

Roche strengthens its position as leading supplier of chemical therapies

This content was published on Aug 31, 2000 In a statement on Thursday, Roche said Kytril provided relief to cancer patients suffering from the severe and debilitating nausea and vomiting associated with chemotherapy. SB will, at the same time, acquire from Roche exclusive rights in the United States and Canada for Coreg, a drug for congestive heart failure and hypertension. Roche will pay…

Internal: Archive

Popular Stories

Most Discussed

Sign in and personalize Swissinfo

Internal: Archive

More

Swiss railways sets sights on share of British market

More

Swiss step out as world leaders in saving books

More

Fewer houses built in first quarter

More

Leonardo da Vinci as artist, scientist and engineer

More

Inflation falls to 10-month low

More

Basel raises ceiling with new building

More

Swiss see Mozambique as example for Africa

More

Swiss diplomat replaces Icelander at helm of EFTA

More

Swiss Solar prize rewards green-thinkers

More

Roche strengthens its position as leading supplier of chemical therapies

Popular Stories

Most Discussed